Lupin signs an agreement with National Chemical Laboratory & DST
IR@NCL: CSIR-National Chemical Laboratory, Pune
View Archive InfoField | Value | |
Title |
Lupin signs an agreement with National Chemical Laboratory & DST
|
|
Subject |
Continuous purification process development
Biosimilar monoclonal antibody therapeutic Controlled chromatography processes Biopharmaceuticals Biologics Monoclonal antibodies |
|
Description |
Pharma major Lupin has signed an agreement with CSIR-National Chemical Laboratory (CSIR-NCL, Pune) and Department of Science and Technology, (DST, Delhi) for conducting research on a continuous purification process development of a biosimilar monoclonal antibody therapeutic (mAb).
Through this research collaboration, CSIR-NCL and Lupin would together work towards the development of a novel continuous purification process for manufacturing mAb therapeutics.
|
|
Date |
2018-06-06T09:22:43Z
2018-06-06T09:22:43Z 2018-03-08 |
|
Type |
Newspaper Article
|
|
Identifier |
http://hdl.handle.net/20.500.12252/3941
|
|
Language |
en
|
|
Format |
application/pdf
|
|
Publisher |
Times of India
|
|